Compound Detail
CHEMBL1783261
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL1783261 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | QGYLDRPCDBYKAP-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
1
PK Parameters
4
Publications
0
Known Names
Molecular Properties
382.4
MW (Da)
2.01
ALogP
7
HBA
3
HBD
119.6
PSA (Ų)
0.53
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
Ki 1 meas. best 6.96
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| GABA-A receptor; alpha-2/beta-3/gamma-2 CHEMBL2094130 | Ki | 6.96 | 6.96 | 109.7 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 8.6 | mL.min-1.g-1 | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| GABA-A receptor; alpha-2/beta-3/gamma-2 | Ki | = | 109.65 | nM | 6.96 | Displacement of [3H]flunitrazepam from benzodiazepine binding site GABAA alpha2b... | 21498079 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 21498079 | 10.1016/j.bmc.2011.03.035 | GABA-A receptor; alpha-2/beta-3/gamma-2 | 2 |
| 21498079 | 10.1016/j.bmc.2011.03.035 | No relevant target | 1 |
| 21498079 | 10.1016/j.bmc.2011.03.035 | Liver microsomes | 1 |
| 21498079 | 10.1016/j.bmc.2011.03.035 | GABA-A receptor; alpha-1/beta-2/gamma-2 | 1 |
Data from ChEMBL 36 via Core Engine